Olympus Takes Stake in Dutch Startup PamGene; Cos to Jointly Develop Microarrays

Mar 14, 2001

NEW YORK, March 14 - PamGene, a Dutch microarray startup, and Olympus Optical have agreed to jointly develop a platform for manufacturing and analyzing DNA microarrays, the companies said Wednesday.

As part of the alliance, Olympus has made a "significant" equity investment in PamGene, based in Den Bosch, the Netherlands. Exact financial details were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Quickly, Quickly

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

Twisting the Results

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

'Right to Try' Heads Toward Law

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

This Week in Genome Research

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.

Main menu